Bicycle Therapeutics plc (BCYC)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20268 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Bicycle Therapeutics plc’s names, not what it holds today.
6 published
6 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jun 6, 2017 | 9,670,484 | Methods and compositions | Biotechnology | BICYCLE THERAPEUTICS LIMITED |
| Jun 6, 2017 | 9,670,482 | Multispecific peptides | Biotechnology | BICYCLE THERAPEUTICS LIMITED |
| May 23, 2017 | 9,657,288 | Connector compound peptide phage display | Biotechnology | BICYCLE THERAPEUTICS LIMITED |
| May 9, 2017 | 9,644,201 | Structured peptide processing | Biotechnology | BICYCLE THERAPEUTICS LIMITED |
| Dec 13, 2016 | 9,518,081 | Peptide libraries | Biotechnology | BICYCLE THERAPEUTICS LIMITED |
| Jul 15, 2014 | 8,778,844 | Structured peptide processing | Biotechnology | BICYCLE THERAPEUTICS LIMITED |
| Apr 1, 2014 | 8,685,890 | Multispecific peptides | Biotechnology | BICYCLE THERAPEUTICS LIMITED |
| Mar 25, 2014 | 8,680,022 | Methods and compositions | Biotechnology | BICYCLE THERAPEUTICS LIMITED |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jul 19, 2018 | 2018/0200378 | COMPOUNDS FOR TREATING CANCER | Pharmaceuticals | BICYCLE THERAPEUTICS LIMITED · patent 10,624,968 granted from it |
| Jun 21, 2018 | 2018/0169254 | METHODS FOR TREATING CANCER | Pharmaceuticals | BICYCLE THERAPEUTICS LIMITED · patent 10,441,663 granted from it |
| Mar 9, 2017 | 2017/0067045 | PEPTIDE LIBRARIES | Biotechnology | BICYCLE THERAPEUTICS LIMITED |
| Feb 18, 2016 | 2016/0046928 | STRUCTURED PEPTIDE PROCESSING | Biotechnology | BICYCLE THERAPEUTICS LIMITED · patent 9,644,201 granted from it |
| Feb 18, 2016 | 2016/0046673 | MODULATION OF STRUCTURED POLYPEPTIDE SPECIFICITY | Pharmaceuticals | BICYCLE THERAPEUTICS LIMITED · patent 10,118,947 granted from it |
| Feb 4, 2016 | 2016/0031939 | MODIFICATION OF POLYPEPTIDES | Biotechnology | BICYCLE THERAPEUTICS LIMITED · patent 9,932,367 granted from it |
| Jun 18, 2015 | 2015/0166988 | METHODS AND COMPOSITIONS | Biotechnology | BICYCLE THERAPEUTICS LIMITED · patent 9,670,484 granted from it |
| Sep 18, 2014 | 2014/0274759 | MODIFICATION OF POLYPEPTIDES | Biotechnology | BICYCLE THERAPEUTICS LIMITED |
| Sep 11, 2014 | 2014/0256596 | MODULATION OF STRUCTURED POLYPEPTIDE SPECIFICITY | Pharmaceuticals | BICYCLE THERAPEUTICS LIMITED · patent 10,800,813 granted from it |
| Sep 4, 2014 | 2014/0249292 | MODULATION OF STRUCTURED POLYPEPTIDE SPECIFICITY | Pharmaceuticals | BICYCLE THERAPEUTICS LIMITED · patent 9,994,617 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.